Search - tctmd.com

Displaying 261 - 280 of 422

Sort: Relevancy | Date

News Daily News

OCT Reveals Potential Causes of Very Late Stent Thrombosis

Caitlin E. Cox

January 19, 2016

News Daily News

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

L.A. McKeown

January 12, 2016

News Daily News

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Michael O'Riordan

January 12, 2016

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

News Daily News

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Michael O'Riordan

December 07, 2015

News Conference News AHA 2015

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Yael L. Maxwell

November 10, 2015

News Daily News

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

Yael L. Maxwell

October 26, 2015

News Industry News

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

October 20, 2015

News Conference News TCT 2015

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

October 13, 2015

News Daily News

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

Todd Neale

September 21, 2015

News Industry News

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

September 16, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Daily News

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Todd Neale

August 31, 2015

News Daily News

CAD Location May Influence Need for Prolonged DAPT Post-PCI

Caitlin E. Cox

August 24, 2015

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

Advertisement

OCT Reveals Potential Causes of Very Late Stent Thrombosis

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

CAD Location May Influence Need for Prolonged DAPT Post-PCI

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content